The Role of the Inflammasome in Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are chronic, progressive disorders that occur in the central nervous system (CNS). They are characterized by the loss of neuronal structure and function and are associated with inflammation. Inflammation of the CNS is called neuroinflammation, which has been implicated in most neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). Much evidence indicates that these different conditions share a common inflammatory mechanism: the activation of the inflammasome complex in peripheral monocytes and in microglia, with the consequent production of high quantities of the pro-inflammatory cytokines IL-1β and IL-18. Inflammasomes are a group of multimeric signaling complexes that include a sensor Nod-like receptor (NLR) molecule, the adaptor protein ASC, and caspase-1. The NLRP3 inflammasome is currently the best-characterized inflammasome. Multiple signals, which are potentially provided in combination and include endogenous danger signals and pathogens, trigger the formation of an active inflammasome, which, in turn, will stimulate the cleavage and the release of bioactive cytokines including IL-1β and IL-18. In this review, we will summarize results implicating the inflammasome as a pivotal player in the pathogenesis of neurodegenerative diseases and discuss how compounds that hamper the activation of the NLRP3 inflammasome could offer novel therapeutic avenues for these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, caspase-1 also induces pyroptosis, which is characterized by gasdermin D (GSDMD) mediated plasma membrane rupture.347”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [347]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Mechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,503
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“Moreover, caspase-1 also induces pyroptosis, which is characterized by gasdermin D (GSDMD) mediated plasma membrane rupture.(347) Numerous inflammasomes have thus far been identified.”
BackgroundResultNeuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
Rauf, A., Badoni, H., Abu-Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P., & Mubarak, M. S. (2022) · Molecules · doi:10.3390/molecules27103194 · Cited by 306
“The inflammasome, nucleotidebinding oligomerization domain leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3), is the most intensively investigated inflammasome, which has been reported as a critical player in neurodegenerative diseases [10].”
BackgroundRetractedSalaudeen, M. A., Bello, N., Danraka, R. N., & Ammani, M. L. (2024) · Biomolecules · doi:10.3390/biom14030305 · Cited by 175
“…ischemia, the activation of inflammasomes leads to the activation of caspase-1, which cleaves pro-IL-1 β and IL-17 to produce IL-1 β and IL-17, respectively, both of which are key inflammatory cytokines, inducing neuronal death along with other pro-inflammatory factors during pyroptosis [44].”
BackgroundRoles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 143
Yang, K., Zeng, L., Yuan, X., Wang, S., Ge, A., Xu, H., Zeng, J., & Ge, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113611 · Cited by 104
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Mallick, R., Basak, S., Chowdhury, P., Bhowmik, P., Das, R. K., Banerjee, A., Paul, S., Pathak, S., & Duttaroy, A. K. (2025) · Pharmaceuticals · doi:10.3390/ph18010104 · Cited by 119
“Numerous neurodegenerative diseases, including MS, ALS, PD, and AD, have been linked to inflammasome activation [141].”
Seyedsadr, M., Wang, Y., Elzoheiry, M., Gopal, S. S., Jang, S., Duran, G., Chervoneva, I., Kasimoglu, E., Wrobel, J. A., Hwang, D., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221007120 · Cited by 98
“The role of activated NLRP3 inflammasome in MS is supported by increased NLRP3 inflammasome–induced caspase-1 and IL-18 gene expression in PBMCs (34, 35) and caspase-1 and IL-1 β proteins in CSF of RRMS patients (26).”
BackgroundTüfekçi, K. U., Eltutan, B. I., Isci, K. B., & Genç, Ş. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00435-w · Cited by 94
Neuroinflammation in Parkinson"s Disease and its Treatment Opportunities
Çınar, E., Tel, B. C., & Şahin, G. (2022) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2022.2022-7-100 · Cited by 93
Bonifacino, T., Zerbo, R. A., Balbi, M., Torazza, C., Frumento, G., Fedele, E., Bonanno, G., & Milanese, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212236 · Cited by 85
“We should also consider that genetic factors not only affect MNs, but also actively contribute to the degeneration or the activation of other CNS cells such as astrocytes and microglia, leading to neuroinflammation and other pathological phenomena [68].”
BackgroundCui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 85
Bocheva, G., Bakalov, D. V., Iliev, P., & Tafradjiiska-Hadjiolova, R. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105122 · Cited by 268
“…that these different age-related neurodegenerative conditions share a common inflammatory mechanism with the activation of the NLRP3 inflammasome complex in microglia and peripheral monocytes, with a consequent increased production of pro-inflammatory cytokines (e.g., IL-1 β and IL-18) [120].”
BackgroundTraumatic brain injury in women across lifespan
Blaya, M. O., Raval, A. P., & Bramlett, H. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105613 · Cited by 70
Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases
Pan, I., Issac, P. K., Rahman, M. M., Guru, A., & Arockiaraj, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03691-3 · Cited by 67
“It is still under debate whether neuroinflammation triggers protein misfolding or whether misfolded α-syn promotes neuroinflammation to initiate PD pathology [4].”
Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases
Brahadeeswaran, S., Sivagurunathan, N., & Latchoumycandane, C. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02683-5 · Cited by 66
Li, J., Xiang, H., Huang, C., & Lu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.797298 · Cited by 58
Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases
Calabrese, L., Fiocco, Z., Mellett, M., Aoki, R., Rubegni, P., French, L. E., & Satoh, T. K. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad421 · Cited by 59
Park, H. R., & Yang, E. J. (2021) · Diagnostics · doi:10.3390/diagnostics11091546 · Cited by 60
“Excessive oxidative stress-induced inflammation could have serious effects in neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and ALS [13].”
BackgroundTian, D., Li, W., Heffron, C. L., Wang, B., Mahsoub, H. M., Sooryanarain, H., Hassebroek, A. M., Clark‐Deener, S., LeRoith, T., & Meng, X. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201862119 · Cited by 52
The IL-1 Family and Its Role in Atherosclerosis
González, L., Rivera, K., Andía, M. E., & Martínez-Rodríguez, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010017 · Cited by 52
Microglia-mediated neuroinflammation in traumatic brain injury: a review
Obukohwo, O. M., Oreoluwa, O. A., Andrew, U. O., & Williams, U. E. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09995-4 · Cited by 53
“The NLRP3 inflammasome is a multi-protein com - plex that consists of NLRP3, the adaptor protein ASC, and pro-caspase-1 [ 49 ].”
Pyroptosis in Steatohepatitis and Liver Diseases
Knorr, J., Wree, A., & Feldstein, A. E. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167271 · Cited by 51
Litwiniuk, A., Baranowska-Bik, A., Domańska, A., Kalisz, M., & Bik, W. (2021) · Pharmaceuticals · doi:10.3390/ph14121221 · Cited by 51
“NLRP3 inflammasome activation has been implicated in the pathogenesis of AD [1,57].”
BackgroundFan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04516-6 · Cited by 49
“Immune cell infiltration from the periphery into the CNS as well as the inflammatory responses mediated by reactive astrocytes and by activated microglia in the CNS also have been implicated in AD, PD, and MS [9].”
BackgroundExtracellular vesicles: The future of therapeutics and drug delivery systems
Uddin, M. J., Mohite, P. B., Munde, S. V., Ade, N., Oladosu, T. A., Chidrawar, V. R., Patel, R. J., Bhattacharya, S., Paliwal, H., & Singh, S. K. (2024) · Intelligent Pharmacy · doi:10.1016/j.ipha.2024.02.004 · Cited by 59
Yang, Z., Li, Y., & Wang, Z. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030618 · Cited by 40
“They are characterized by the loss of neuronal structure and function [88] lead to Information transmission disorder for neuron-to-neuron.”
BackgroundKlotho an Autophagy Stimulator as a Potential Therapeutic Target for Alzheimer’s Disease: A Review
Fung, T., Iyaswamy, A., Sreenivasmurthy, S. G., Krishnamoorthi, S., Guan, X.-J., Zhu, Z., Su, C.-F., Liu, J., Kan, Y., Zhang, Y., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030705 · Cited by 49
“These results support an important role for the NLRP3/caspase-1 pathway in the pathogenesis of AD [23,94,95].”
BackgroundGhassab, F. T., Mahmoudi, F. S., Tinjani, R. T., Meibodi, A. E., Zali, M. R., & Yadegar, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122748 · Cited by 41
Tondo, G., Marchi, F. D., Bonardi, F., Menegon, F., Verrini, G., Aprile, D., Anselmi, M., Mazzini, L., & Comi, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113098 · Cited by 46
Adnan, M., Siddiqui, A. J., Bardakçi, F., Surti, M., Badraoui, R., & Patel, M. B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1593264 · Cited by 46
Liu, Y., Tan, Y., Zhang, Z., Li, H., Yi, M., Zhang, Z., Hui, S., & Peng, W. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101831 · Cited by 37
Arbo, B. D., Schimith, L. E., dos Santos, M. G., & Hort, M. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174800 · Cited by 34
Boraschi, D., Italiani, P., Migliorini, P., & Bossù, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128190 · Cited by 46
The Role of miR-23b in Cancer and Autoimmune Disease
Guo, Y.-X., Wang, N., Wu, W.-C., Li, C., Chen, R.-H., Zhang, Y., & Li, X. (2021) · Journal of Oncology · doi:10.1155/2021/6473038 · Cited by 32
Wang, T., Yin, Y., Jiang, X., Ruan, Y., Xu, J., Hu, X., Li, T., Chu, L., & Li, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-41101-9 · Cited by 36
Yuan, Y., Fan, X., Guo, Z., Zhou, Z., & Gao, W. (2022) · Analytical Cellular Pathology · doi:10.1155/2022/3634908 · Cited by 35
“Inflammation can worsen tissue necrosis and apoptosis following SCI, according to studies, and the NLRP3 inflammasome plays a key role in this [18, 33, 34].”
BackgroundNeuroinflammation: A Critical Factor in Neurodegenerative Disorders
Khoury, Z. S., Sohail, F., Wang, J., Mendoza, M., Raake, M., Silat, M. T., Bathinapattla, M. R., Sadeghzadegan, A., Meghana, P., & Paul, J. (2024) · Cureus · doi:10.7759/cureus.62310 · Cited by 44
“Neuroinflammation has been linked, in recent research, to the beginning, maintenance, and amplification of neuronal dysfunction in the neurodegenerative process of disorders such as Alzheimer’s, Parkinson’s, epilepsy, stroke, Huntington’s, and ALS [36].”
BackgroundFu, R., Tsai, C.-W., Chiu, S., Liu, S., Chiang, Y.-T., Kuo, Y.-H., Shyu, W., & Lin, S. (2022) · Cells · doi:10.3390/cells11193128 · Cited by 31
“The activation of the NLRP3 inflammasomes in microglial cells plays a vital role in the establishment of neurodegenerative diseases, including ALS, which cause the degeneration of surrounding motor neurons [45].”
BackgroundMolecular Foundations of Inflammatory Diseases: Insights into Inflammation and Inflammasomes
Kim, M. E., & Lee, J. S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46010030 · Cited by 33
“This demonstrates the complex function of inflammasomes in neuroinflammatory processes and suggests that they may have a role in the development of neurodegenerative disorders [101,102].”
BackgroundValenzuela-Arzeta, I. E., Soto-Rojas, L. O., Flores-Martinez, Y. M., Delgado-Minjares, K. M., Gatica-García, B., Mascotte-Cruz, J. U., Nava, P., Aparicio‐Trejo, O. E., Reyes-Corona, D., Martínez-Dávila, I. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054628 · Cited by 29
“This evolutionarily conserved enzyme proteolytically cleaves the precursor interleukin 1β (IL-1 β) to an active secreted molecule that can cause neuronal damage through various downstream signaling pathways [35].”
BackgroundZhu, J., Zhou, F., Zhou, Q., Xu, Y., Li, Y., Huang, D., Chen, L., Liu, A., Zou, F., & Meng, X. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac115 · Cited by 34
A Decade of Dedication: Pioneering Perspectives on Neurological Diseases and Mental Illnesses
Tanaka, M., & Vécsei, L. (2024) · Biomedicines · doi:10.3390/biomedicines12051083 · Cited by 28
“Neuroinflammation is increasingly recognized as a significant factor in a variety of brain diseases, with microglia and monocytes playing an important role in the robust activation of the NOD-, LRR-and pyrin domain-containing protein 3 (NLRP3) inflammasome [128–130].”
BackgroundKattan, D., Barsa, C., Mekhijian, S., Shakkour, Z., Jammoul, M., Doumit, M., Zabala, M. C. P., Darwiche, N., Eid, A. H., Mechref, Y. S., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104969 · Cited by 28
Molecular mechanism of PANoptosis and programmed cell death in neurological diseases
Hou, K., Pan, W., Liu, L.-Y., Yu, Q., Ou, J. T., Li, Y., Yang, X., Lin, Z., Yuan, J. H., & Fang, M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106907 · Cited by 38
“Furthermore, therapeutic strategies directly modulating inflammasome activation demonstrate considerable promise in attenuating neuroinflammatory cascades and preserving neuronal viability (Ahn et al., 2017; Piancone et al., 2021).”
MitoQ Is Able to Modulate Apoptosis and Inflammation
Piscianz, E., Tesser, A., Rimondi, E., Melloni, E., Celeghini, C., & Marcuzzi, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094753 · Cited by 28
“The most investigated inflammasome is NLRP3 (NACHT, LRR and PYD domainscontaining protein 3), which has been associated with various diseases considering that caspase 1 activation is crucial for starting inflammation in response to injury or infection [23].”
BackgroundYang, K., Zeng, L., He, Q., Wang, S., Xu, H., & Ge, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1250918 · Cited by 30
Mechanistic insights of neuronal death and neuroprotective therapeutic approaches in stroke
Li, C., Luo, Y., & Li, S. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01324 · Cited by 35
“Upon cerebral ischemic stress, the inflammasome-mediated activation of caspase-1 leads to the proteolytic processing of pro-IL-1β and pro-IL-18 into their active forms, IL-1β and IL-18, respectively (Piancone et al., 2021).”
Merighi, S., Nigro, M., Travagli, A., Pasquini, S., Borea, P. A., Varani, K., Vincenzi, F., & Gessi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095056 · Cited by 26
“Thus, caspase-11 does not directly cleave interleukins but through induction of pyroptosis, and consequent potassium efflux triggers NLRP3 inflammasome and caspase-1 activation, which in turn is responsible for IL-1β secretion [45,47].”
BackgroundEmerging mechanisms and functions of inflammasome complexes in teleost fish
Chang, M. X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1065181 · Cited by 30
From Low-Grade Inflammation in Osteoarthritis to Neuropsychiatric Sequelae: A Narrative Review
Naumovs, V., Groma, V., & Mednieks, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416031 · Cited by 21
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease
Seplovich, G., Bouchi, Y., Vaccari, J. P. D. R., Pareja, J. C. M., Reisner, A., Blackwell, L. S., Mechref, Y. S., Wang, K., Tyndall, J. A., Tharakan, B., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00107 · Cited by 22
Lo, J., Wu, H., Liu, C., Chang, K., Lee, P., Liu, P., Huang, S., Wu, P., Lin, T.-C., Lai, Y., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087300 · Cited by 21
“NLRP3 inflammasome plays a central role in the pathogenesis of many inflammatory disorders, including AD, by secreting high quantities of the pro-inflammatory cytokines such as IL-1β [8].”
BackgroundMechanism of effect and therapeutic potential of NLRP3 inflammasome in spinal cord injury
Gu, H.-Y., & Liu, N. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115059 · Cited by 23
Tang, S., Li, C., Suo, Z.-W., Xu, Y., Wei, K., Zhao, L., Huang, H., Liu, X., Liu, D., & Li, X. (2023) · Molecules · doi:10.3390/molecules28041575 · Cited by 17
“Many types of neurological diseases are related to neuroinflammation mediated by the NLRP3 inflammasome, such as AD, PD, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and depression [32].”
BackgroundWang, C., Cui, C., Xie, X., Chen, B., Feng, L., & Jiang, P. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06565-1 · Cited by 19
“Elevated serum levels of NLRP3 and pro-inflammatory mediators are observed in patients exhibiting neuroinflammation (Piancone et al. 2021 ).”
Gastaldi, S., Boscaro, V., Gianquinto, E., Sandall, C. F., Giorgis, M., Marini, E., Blua, F., Gallicchio, M., Spyrakis, F., MacDonald, J. A., et al. (2021) · Molecules · doi:10.3390/molecules26133975 · Cited by 19
“…29 was converted into its O ‐ hydroxysuccinimide ester 29a using dicyclohexylcarbodiimide (DCC) and N ‐ hydroxysuccinimide (NHS) and then reacted with the aminoesters 30 – 31 to afford the intermediates 32 and 33 , which were hydrolysed in basic medium (NaOH 2.5 M) to give the acids 34 and 35 .”
InfluentialNLRP3 inflammasome-mitochondrion loop in autism spectrum disorder
Vallese, A., Cordone, V., Ferrara, F., Guiotto, A., Gemmo, L., Cervellati, F., Hayek, J., Pecorelli, A., & Valacchi, G. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.10.297 · Cited by 19
The Gut-Brain Axis in Alzheimer’s Disease: Exploring Microbial Influences and Therapeutic Strategies
Mustafa, M. A., Vadia, N., Varma, P., Al‐Shaker, H., Mohanty, B., Dhyani, A., Kaur, I., Chauhan, A. S., & Garg, G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05474-4 · Cited by 19
“In addition to the microbial influences on inflammation, several inflammation-inducing stimuli such as PAMPs and DAMPs are recognized by inflammasomes, multiprotein complexes that mediate immune responses [178].”
Priming and release of cytokine IL-1β in microglial cells from the retina
Campagno, K. E., Lu, W., Sripinun, P., Albalawi, F., Cenaj, A., & Mitchell, C. H. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2025.110246 · Cited by 18
Quantum Biology Research Meets Pathophysiology and Therapeutic Mechanisms: A Biomedical Perspective
Calvillo, L., Redaelli, V., Ludwig, N. G., Qaswal, A. B., Ghidoni, A., Faini, A., Rosa, D., Lombardi, C., Pengo, M. F., Bossolasco, P., et al. (2022) · Quantum Reports · doi:10.3390/quantum4020011 · Cited by 22
Regulatory T cell expansion prevents retinal degeneration in type 2 diabetes
Llorián‐Salvador, M., Pérez-Martínez, D., Tang, M., Duarri, A., García‐Ramírez, M., Deàs-Just, A., Álvarez-Guaita, A., Ramos‐Perez, L., Bogdanov, P. M., Gomez-Sanchez, J. A., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03323-0 · Cited by 17
Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease—A Review
Moradi, F., & Mokhtari, T. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70071 · Cited by 18
“Subsequently, IL ‐ 1 β and IL ‐ 18 initiate multiple signaling pathways and drive inflammatory responses, ultimately resulting in neuronal injury or death [100].”
Zhang, X., Zhang, Y., Peng, X., Yang, L., Miao, J., Yue, Y., Wang, Y., Wang, X., Zhu, C., & Song, J. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01540-6 · Cited by 19
“These pathological processes underlie the characteristic features of WMI, underscoring the importance of targeting neuroinflammation as a therapeutic approach (Piancone et al. 2021; Van Steenwinckel et al. 2024).”
Nohesara, S., Abdolmaleky, H. M., Pirani, A., & Thiagalingam, S. (2025) · Cells · doi:10.3390/cells14131027 · Cited by 16
“Neurodegenerative diseases such as AD and PD are characterized by the progressive loss of neuronal cells and disturbances in their function which in turn give rise to psychological disability and cognitive impairment [5].”
Zhou, Z., Li, D., Fan, X., Lin, S., Yuan, Y., Zhuang, P., Hu, H., Ge, M., Chen, S., & Mei, X. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.110465 · Cited by 15
Jin, X., Dong, W., Chang, K., & Yan, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117850 · Cited by 15
The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Ribarič, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084358 · Cited by 18
“…the result of impaired insulin signalling, leading to (a) the FOXO1-promoted activation of pro-apoptosis factors and reduced MT function [2,235,237,351]; (b) GSK3-increased α -syn aggregation, NF-κ B-enhanced NLRP3 inflammasome activation, pro-inflammatory cytokine signalling ((IL)-1 β , -6; TNF…”
BackgroundZang, Y., Liu, K., Wang, W., Li, C., Ma, J., Yang, J., Chen, X., Wang, X., & Zhang, D. (2021) · Molecules · doi:10.3390/molecules26051303 · Cited by 13
Mir, P. A., Kumar, N. G., Bhutia, G. T., Chaudhary, P., Kaur, G., & Gupta, S. K. (2026) · GeroScience · doi:10.1007/s11357-025-02062-1 · Cited by 14
Cadmium‐induced pyroptosis is mediated by PERK / TXNIP / NLRP3 signaling in SH‐SY5Y cells
Li, Z., Shi, Y., Wang, Y., Qi, H., Chen, H., Li, J., & Li, L. (2023) · Environmental Toxicology · doi:10.1002/tox.23861 · Cited by 15
“of pro-inflammatory proteins is relevant to neurodegenerative disorder.(33) However, it is still not known whether cadmium can activate”
BackgroundChen, W., He, L., Pei, H., Li, J., Zhao, Y. D., Zong, Y., Kan, H., He, Z., & Du, R. (2023) · Aging · doi:10.18632/aging.204627 · Cited by 12
Ahmed, S., Pasam, T., & Afreen, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010486 · Cited by 13
“Several inflammasome sensors have been identified, including members of the nucleotide-binding domain leucine-rich repeat (NLR) family—NLRP1, NLRP2, NLRP3, and NLRC4—as well as PYHIN family members (non-NLR family), such as absent in melanoma 2 (AIM2) and IFI16 [50,51].”
Emerging functions and therapeutic targets of IL‐38 in central nervous system diseases
Gao, Y., Cai, L., Wu, Y., Jiang, M., Zhang, Y., Ren, W., Song, Y., Li, L., Lei, Z., Wu, Y., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14550 · Cited by 12
Pan, J., Xie, J., Huang, L., Wu, Q., Tang, D., Jin, Q., Wang, W., & Yang, M. (2023) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12670 · Cited by 12
“Nod-like receptor pyrin containing 3 (NLRP3) inflammasome, a member of the NLR family, is a major participant in mediating neuroinflammation.(2) Clinical research has suggested that NLRP3 inflammasome was sig-”
BackgroundOx-inflammasome involvement in neuroinflammation
Vallese, A., Cordone, V., Pecorelli, A., & Valacchi, G. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.010 · Cited by 15
Chow, T. W., Raupp, M. D., Reynolds, M. W., Li, S., Kaeser, G. E., & Chun, J. J. M. (2024) · Pharmaceuticals · doi:10.3390/ph17040408 · Cited by 10
“NRTIs are also known to inhibit inflammasome activation [25–27], which has been implicated in the etiology of AD [28], supporting further exploration of current and novel NRTIs and allosteric NNRTIs designed against endogenous RTs for the treatment of AD [28–30].”
BackgroundMercer, A., Sancandi, M., MacLatchy, A., & Lange, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011168 · Cited by 10
Liang, J.-Y., Yuan, X., Jiang, J., Zhang, P., & Kuang-Tan (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115167 · Cited by 13
Wang, J., Li, Y., & Xia, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656165 · Cited by 12
Mellado, S., Morillo-Bargues, M. J., Perpiñá-Clérigues, C., Touahri, N., García-García, F., Moreno‐Manzano, V., Guerri, C., & Pascual, M. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01397 · Cited by 7
“Considering the involvement of the inflammasome receptors in the neuroinflammatory processes (Piancone et al., 2021) and behavioral dysfunctions (Jin et al., 2019; Hou et al., 2020), the present findings provide evidence that the intravenous administration of MSC-EVs restores the activation of the…”
BackgroundBioactivities and Structure–Activity Relationships of Harmine and Its Derivatives: A Review
Liu, Q., Yang, C., Qi, J., Shen, Q., Ye, M., Li, H.-Y., & Zhang, L. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402953 · Cited by 15
“They play crucial roles in innate immunity and are key regulators of inflammation in both health and disease [79].”
The Immunomodulatory Functions of BTK Inhibition in the Central Nervous System
Cao, T., Wang, Z., & Zhu, X. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s389958 · Cited by 10
“After receiving stimuli as the second signal, NLRP3 oligomerizes and the NACHT domain of NLRP3 is activated by ATP and NEK7 binding.(81,82) Next, the PYD domain recruits the adaptor ASC through PYD-PYD interaction.”
BackgroundMethodTylek, K., Trojan, E., Leśkiewicz, M., Idrissi, I. G. E., Lacivita, E., Leopoldo, M., & Basta‐Kaim, A. (2023) · Cells · doi:10.3390/cells12212570 · Cited by 8
“The oligomerised PYCARD CARDs then form the platform for caspase-1 CARD to nucleate into fi laments, which, in turn, activates caspase-1 [54,68].”
BackgroundPyrzanowska, J. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2051955 · Cited by 8
“subsequent production of interleukins IL-1β and IL-18 [40].”
BackgroundKwakowsky, A., Chawdhary, B., de Souza, A., Meyer, E., Kaye, A. H., Green, C. R., Stylli, S. S., & Danesh-Meyer, H. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417454 · Cited by 8
Liu, B., Luo, W., Huang, L., Wei, C., Huang, X., Liu, J., Tao, R., Mo, Y., & Li, X. (2024) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175241238577 · Cited by 12
Bertinaria, M. (2021) · Molecules · doi:10.3390/molecules26226912 · Cited by 7
The regulatory effect of intermittent fasting on inflammasome activation in health and disease
Wang, C., Liu, Z., Cai, J., & Xu, X. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad104 · Cited by 6
Saiyed, N., Yılmaz, A., Vishweswariah, S., Maiti, A. K., Ustun, I., Bartolone, S. N., Hughes, T. B., Thorpe, R. J., Osentoski, T., Ruff, S., et al. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220081 · Cited by 7
“Increasing evidence suggests that inflammatory responses play a critical role in the pathogenesis of AD [10, 11].”
BackgroundYang, R., Deng, M., Yang, L.-K., Wang, G., Ma, J., Wen, Q., Gao, N., & Qiao, H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.032 · Cited by 6
Rimal, N., Khanal, S., Bohara, G., & Choi, D. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110643 · Cited by 7
SP1-Driven FOXM1 Upregulation Induces Dopaminergic Neuron Injury in Parkinson’s Disease
Li, D., & Gao, L. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03854-2 · Cited by 7
“…death [1], microglia [2], and the innate immune cells in the brain [3] can be chronically activated, followed by a self-renewing cycle of micro-glial activation [4], chronic inflammation [5], and further neuron injury, which is involved in the progressive nature of Parkinson’s disease (PD) [6, 7].”
Zoila, F., de Stefano, M. I., Sgobbio, A., Panaro, M. A., Maffione, A. B., Antonucci, L., Benameur, T., Massaro, M., Gaban, S. V. F., Filannino, F. M., et al. (2025) · Sports · doi:10.3390/sports13120458 · Cited by 6
Cheng, X., Li, Y., Fan, Y.-B., Zhao, H., Li, L., Lu, C., Zhu, L.-H., & Niu, Q. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108462 · Cited by 4
“Neuroinflammation is involved in the development of many neuro-degenerative diseases [23,24]; however, its role in the SMA has not been confirmed.”
BackgroundOfirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome
Mollard, A., Bursey, D., Burnett, W. J., Avei, T., Bearss, B., Subbiah, R., Chaugule, V. K., Tripuraneni, N. S., Bijpuria, S., Teichert, R., et al. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2542856 · Cited by 5
“…driving disability, lost productivity, and escalating healthcare costs [1,2]. although diverse in their clinical presentations, these diseases share common innate immune pathways, notably involving NlRP3 inflammasome activation, which remain inadequately addressed by existing therapies [3–9].”
Alvarez, E. C., Sfogliarini, C., Rosa, F. L., Saresella, M., Dolci, M., Vegeto, E., Taramelli, D., Basilico, N., & Clerici, M. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03574-5 · Cited by 4
“NLRP3 activation is also involved in other neurodegenerative and neuro-developmental conditions, including Parkinson’s disease, multiple sclerosis (MS), and autism spectrum disorder (ASD) [64].”
Self-citationToledano‐Díaz, A., Álvarez, M. I., & Tolédano, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221123896 · Cited by 5
The Neglected Sibling: NLRP2 Inflammasome in the Nervous System
Ducza, L., & Gaál, B. (2023) · Aging and Disease · doi:10.14336/ad.2023.0926-1 · Cited by 8
“…compound MCC950 (also termed as CRID3, CP-456773), endowed with NLRP3 selectivity, showed therapeutic improvement in several preclinical models such as experimental autoimmune encephalomyelitis, such as AD and PD [229-232], nevertheless it failed in clinical trials because of off-target toxicity.”
Zeng, A., Quan, Y., Tao, H., Dai, Y., Song, L., & Zhao, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083561 · Cited by 5
Microglia Heterogeneity: A Single-cell Concerto
Wang, L., Wu, H., Zhang, S., He, D., Chen, Y., Xue, J., You, L., Liu, Q., & Li, W. (2022) · Human Brain · doi:10.37819/hb.001.001.0208 · Cited by 3
“Neuroinflammation contributes to various brain pathologies, including infection, injury, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and lipopolysaccharide (LPS) challenge (Piancone et al., 2021).”
Background
Metadata
- Authors
- Piancone, F., La Rosa, F., Marventano, I., Saresella, M., & Clerici, M.
- Affiliations
- Don Carlo Gnocchi Foundation (IT)
- IRCCS Fondazione Don Carlo Gnocchi, 20148 Milano, Italy
- University of Milan (IT)
- Corresponding author
- Piancone, Federica
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-02-11
- Volume
- 26
- Issue
- 4
- Pages
- 953
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7916884
- OpenAlex
- W3128695211
- Cited by
- 144
- References
- 99
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 29 · 2023: 27 · 2022: 28 · 2021: 12
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- inflammasome, neurodegenerative diseases, neuroinflammation, NLRP3 inflammasome, IL-1β, IL-18, caspase-1, NOD-like receptors, microglia, monocytes, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, inflammasome inhibitors, neuroinflammation therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Humans, Multiple Sclerosis, Parkinson Disease, Signal Transduction, Neurodegenerative Diseases, Interleukin-18, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.